2014
DOI: 10.5021/ad.2014.26.3.424
|View full text |Cite
|
Sign up to set email alerts
|

Gene Mutation Analysis in a Korean Patient with Early-Onset and Recalcitrant Generalized Pustular Psoriasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0

Year Published

2015
2015
2018
2018

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 5 publications
0
8
0
Order By: Relevance
“…Sugiura et al (2013) also revealed the same result and suggested that p.Arg10ArgfsX1(c.115+6T>C) is one of the founder mutations for GPP in the Japanese population. Furthermore, p.Arg10ArgfsX1(c.115+6T>C) was reported in Chinese (Li et al 2013, 2014), Korean (Song et al 2014) and Malay (Setta-Kaffetzi et al 2013) patients with GPP in homozygous/compound heterozygous, or heterozygous state. In current study, by three-dimensional conformation analysis, the mutation could lead to a truncated protein and lose the functional domain.…”
Section: Discussionmentioning
confidence: 94%
“…Sugiura et al (2013) also revealed the same result and suggested that p.Arg10ArgfsX1(c.115+6T>C) is one of the founder mutations for GPP in the Japanese population. Furthermore, p.Arg10ArgfsX1(c.115+6T>C) was reported in Chinese (Li et al 2013, 2014), Korean (Song et al 2014) and Malay (Setta-Kaffetzi et al 2013) patients with GPP in homozygous/compound heterozygous, or heterozygous state. In current study, by three-dimensional conformation analysis, the mutation could lead to a truncated protein and lose the functional domain.…”
Section: Discussionmentioning
confidence: 94%
“…Recent treatment of juvenile DITRA (C115+6T>C/p.Arg10ArgfsX1) with tumor necrosis factor-α blockers (infliximab) was reported to be successful 8 and unsuccessful. 9 Similar treatments in patients with identical mutations result in different outcomes, illustrating the complexity of the disease and its treatment. A recent publication showed a possible correlation between disease severity in DITRA, mutation of the IL36RN gene, and IL36RN protein expression.…”
Section: Discussionmentioning
confidence: 99%
“…IL-36 is overexpressed in psoriatic lesional skin 12 20 . On the other hand, mutations of the gene for IL-36Ra were reported in patients with intractable and severe GPP 14 15 17 . Studies of IL-36 and its antagonist in patients with AGEP have also been reported 16 .…”
Section: Discussionmentioning
confidence: 99%
“…However, comparative immunohistochemical studies between GPP and AGEP are relatively few 7 . Mutations of the gene for IL-36 receptor antagonist (IL-36Ra) were recently reported in patients with GPP and AGEP 14 15 16 17 . Such findings support the idea that a common pathomechanism might exist in the two diseases.…”
Section: Introductionmentioning
confidence: 99%